மெட்டா பகுப்பாய்வு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மெட்டா பகுப்பாய்வு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மெட்டா பகுப்பாய்வு Today - Breaking & Trending Today

Patient-Level VHA Data Show No Association Between Paclitaxel-Coated Devices and Long-Term Mortality


Patient-Level VHA Data Show No Association Between Paclitaxel-Coated Devices and Long-Term Mortality
Created with Sketch.
February 23, 2021 In the first study examining the impact of paclitaxel-coated device (PCD) use on mortality in patients treated within the Veterans Health Administration (VHA), Gutierrez et al found no increased risk of long-term all-cause mortality associated with PCD use. The study was recently published in the
KEY FINDINGS
The rates of 2- and 3-year all-cause mortality were similar between the PCD and non-PCD groups, even when stratified by claudication or critical limb ischemia presentations.
No statistically significant risk in all-cause mortality was seen between the use of PCD and non-PCD devices after adjustment for treatment assignment. ....

Duke University Medical Center , North Carolina , United States , J Antonio Gutierrez , Veterans Health Administration , Centers For Medicare Medicaid Services , National Death Index , Journal Of The American Heart Association , Veterans Affairs Corporate Data Warehouse , American Heart , National Death , Medicaid Services , Veteran 039s Health Administration , Long Term Mortality , Meta Analysis , Paclitaxel Coated Device , Drug Coated Balloon , Drug Eluting Stent , Peripheral Artery Disease , Peripheral Endovascular Intervention , Limb Salvage , டியூக் பல்கலைக்கழகம் மருத்துவ மையம் , வடக்கு கரோலினா , ஒன்றுபட்டது மாநிலங்களில் , ஜு அன்டோனியோ குட்டரெஸ் , மையங்கள் க்கு மருத்துவ மருத்துவ உதவி சேவைகள் ,

Mountain Valley MD Files for Acceleration of Patent Examination for Solubilized Ivermectin


Mountain Valley MD Files for Acceleration of Patent Examination for Solubilized Ivermectin
News provided by
Share this article
 Mountain Valley MD Holdings Inc. (the
Company or
MVMD ) (CSE: MVMD) (FRA: 20MP) is pleased to announce that it has filed for an accelerated review of its macrocyclic lactone solubilization patent with the United States Patent and Trademark Office ( USPTO ).
To support the accelerated patent examination request, the Company has provided the USPTO with new formulation analyses of different diluted concentrations of its Quicksol™ Ivermectin in solution, data that the company had fast-tracked for completion and validation by a third-party CRO.
The Company previously confirmed its ability to make the anti-parasitic drug Ivermectin highly water-soluble without the use of organic solvents, improving its water solubility by nearly 5,000 times and that it had completed its initial safety and improved efficacy in pre-clinical val ....

United States , British Columbia , Mike Farber , Dennis Hancock , Melissa Diaz Musa , Trademark Office , Health Services , Life Sciences At Mountain Valley , Mountain Valley Md Holdings Inc , Ministry Of Health , Critical Care Alliance , Drug Administration , United States Patent , Life Sciences , Mountain Valley , Front Line , Care Alliance , Acting Director , One Page Summary , Clinical Trials Evidence , Meta Analysis , People Live Their Best , Chief Executive Officer , ஒன்றுபட்டது மாநிலங்களில் , பிரிட்டிஷ் கொலம்பியா , மைக் ஃபார்‌பர் ,